Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Ainos, Inc.
On October 14, 2026, Ainos, Inc. amended its bylaws to implement a classified board structure, dividing directors into three classes (Class I, II, and III) effective immediately. The company also updated its corporate governance policies to reflect this structure and assigned current directors to their respective classes with staggered terms.…more
Ainos, Inc.
Ainos has entered into a global exclusive license agreement with BioPhoenix for its VELDONA technology platform. Under the agreement, Ainos secures a total economic framework of approximately $10 million, including an upfront fee of $600,000, while shifting clinical and regulatory funding responsibilities to the partner to reduce its own capital requirements.…more
Ainos, Inc.
Ainos, Inc.는 2026년 2분기 실적을 발표하며 매출 152달러, 순손실 459만 4,731달러를 기록했습니다. 상반기 누적 매출은 313달러, 순손실은 705만 4,531달러로, 주당순손실(EPS)은 2분기 기준 -0.62달러입니다. 회사는 AI Nose 기술의 반도체 및 산업 현장 배치를 지속하고 있으나, 매출 규모가 매우 미미하고 영업 손실이 지속되는 재무 구조를 보이고 있습니다.…more
4 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Ainos Completes VELDONA Tech Transfer, Triggers $600K Payment
Ainos has completed the required technology transfer and data delivery for its VELDONA license agreement. This milestone triggers an initial $600,000 license payment due within 15 business days.…more
●●●●●●●● ●●●●● ●●●●●●
Ainos has completed the delivery of 1,400 AI Nose systems to ASE under a $2.1 million contract, with revenue expected to be recognized starting in the third quarter. The company is also currently negotiating a larger second-phase deployment.…more
●●●●●●●● ●●●●● ●●●●●●
Ainos announced that its VELDONA license includes a $600,000 initial fee and 25% of net sublicensing revenue. The company clarified that the mentioned $10 million framework is not a guaranteed amount.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.